Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue 2, 2002, Pages 129-138

  Stahnke, N ^a   Keller, E ^a   Landy, H ^a   Amendt, P ^a   Bramswig J ^a   Butenandt, O ^a   Esser, K J ^a   Hartmann, K ^a   Haverkamp, F ^a   Heidemann, P ^a   Heinrich, U ^a   Heinze, E ^a   Hesse, V ^a   Hinkel, K G ^a   Irle, U ^a   Kiess, W ^a   Mix, M ^a   Mohnike, K ^a   Muhlenberg R ^a   Muhlendahl K V ^a   Petrykowski, W V ^a   Reinken, L ^a   Roth, C ^a   Sipell, W G ^a   Stubbe, P ^a   Vilser, C ^a   Willgerodt, H ^a   Wollmann, H ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Estrogen supplementation; Final height; GH therapy; Glucose tolerance; Lipids; Oxandrolone; Safety issues; Ullrich Turner syndrome

Indexed keywords

CHLORMADINONE ACETATE; ESTRADIOL VALERATE; GROWTH HORMONE; HUMAN GROWTH HORMONE; NORGESTREL; OXANDROLONE;

ADOLESCENT; BODY HEIGHT; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; PUBERTY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; TURNER SYNDROME; VIRILIZATION;

EID: 0036002589     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2002.15.2.129     Document Type: Review

References (56)

1. Turner syndrome: Demography, auxology and growth during growth hormone therapy in KIGS
2. What is the current status of GH therapy in children with Turner syndrome?
3. ESPE Report: Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders
4. Final height in patients with Turner syndrome treated with growth hormone (n = 117)
5. Final height after long-term growth hormone treatment in Turner syndrome
6. Experience within the Manchester Growth Clinic of growth hormone treatment of girls with Turner syndrome: The influence of duration of treatment on final height
7. Does growth-hormone supplementation affect adult height in Turner's syndrome?
8. Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome
9. Growth hormone therapy for Turner syndrome: Evidence for benefit
10. Growth hormone therapy in Turner syndrome-current uncertainties and future strategies
11. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: Effect on bone maturation and final height
12. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone
13. Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height
14. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome
15. Normalization of height in girls with Turner Syndrome after long-term growth hormone treatment: Results of a randomized dose-response trial
16. Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome
17. GH treatment in Turner's syndrome: Are there new suggestions for paediatricians?
18. Spontaneous growth in Turner's syndrome
19. Standards for children's height at ages 2-9 years allowing for height of parents
20. Growth curve for girls with Turner syndrome
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
22. Spontaneous growth and pubertal development in Turner's syndrome with different karyotypes
23. Bone age maturation during growth promoting and GnRHa treatment in Turner syndrome
24. Factors predictive of response to growth hormone therapy in Turner's syndrome
25. Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects
26. Growth in Turner syndrome: Updating the United States experience
27. Syndrome de Turner: Croissance staturopondérale et maturation osseuses spontanées
28. Accuracy of adult height prediction methods for Turner syndrome using U.S. untreated control data
29. A decade of growth hormone treatment in girls with Turner syndrome in the UK
30. Managing the short stature of Turner syndrome: An evidence-based approach to the suggestion of growth hormone supplementation
31. Predicting the response to recombinant human growth hormone in Turner syndrome: KIGS models KIGS International Board. Kabi International Growth Study
32. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone
33. Growth hormone therapy of Turner syndrome: The impact of age of estrogen replacement on final height
34. Growth hormone deficiency: Growth hormone therapy in the transition from childhood to adult life
35. Turner syndrome adolescents receiving growth hormone are not osteopenic
36. Concluding remarks
37. Oxandrolone treatment of short stature: Effect on predicted mature height
38. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: When should therapy be started in Turner syndrome?
39. Gestörte Glucosetoleranz und Diabetes mellitus bei Ullrich-Turner-Syndrom
40. Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome
41. Natural history of glucose tolerance of relatives of diabetic patients. Low prognostic value of the oral glucose tolerance tests
42. Pathologische Glucosetoleranz und Prae-diabetes
43. Lipid profile, glucose tolerance and insulin sensitivity after more than four years of growth hormone therapy in non-growth hormone deficient adolescents
44. Safety issues in children and adolescents during growth hormone therapy - A review
45. Carbohydrate and lipid metabolism in Turner syndrome: Effect of therapy with growth hormone, oxandrolone, and a combination of both
46. Clinical trials of GH treatment in patients with Turner's syndrome in Japan - A consideration of final height
47. Dose-dependent effect of growth hormone therapy on glucose metabolism in subjects with Turner syndrome
48. Effect of growth hormone and oxandrolone treatment on glucose metabolism in Turner syndrome
49. Oxandrolone therapy in patients with Turner syndrome
50. Leukemia in growth-hormone treated patients: An update, 1992
51. Benign intracranial hypertension induced by growth hormone treatment
52. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study
53. Body proportions during long-term growth hormone treatment in girls with Turner syndrome participating in a randomized dose-response trial
54. Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren